23andMe is testing a $749 “premium” service for deeper health insights, according to several customers who saw a test page for the new product and posted about it on Reddit. First spotted by CNBC, the company served up a test web page to several customers telling them about a service that would allow them to […]
View More 23andMe might soon offer a more comprehensive $749 DNA serviceCategory: biotechnology
Implantable 3D printed organs could be coming sooner than you think
At MBC Biolabs, an incubator for biotech startups in San Francisco’s Dogpatch neighborhood, a team of scientists and interns working for the small startup Prellis Biologics have just taken a big step on the path toward developing viable 3D printed organs for humans. The company, which was founded in 2016 by research scientists Melanie Matheu […]
View More Implantable 3D printed organs could be coming sooner than you thinkThe genomics-focused Illumina Accelerator backs five new companies
Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina Corp., has picked five startups for its seventh accelerator class, the company announced. Wth technology addressing skin microbial therapeutics, fertility science, chronic disease alleviation, post traumatic stress disorder treatments, and services for the biopharmaceutical and clinical research industries; the startups […]
View More The genomics-focused Illumina Accelerator backs five new companiesSouthern California needs to find its hub for it to develop its own tech ecosystem
Recognizing the tens of billions of dollars that the Southern Californian region leaves on the table, because it hasn’t taken its rightful place in the American technology industry, a new group called the Alliance for Southern California Innovation has just released a report to analyze how SoCal can work to assume its pole position. Through interviews with […]
View More Southern California needs to find its hub for it to develop its own tech ecosystemAll-star team of synthetic biologists raise $53 million for cancer therapy startup Senti
A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a longtime researcher at the Massachusetts Institute of Technology and one of the founding fathers of synthetic biology, Senti’s aim is nothing less than developing therapies that are tailored… Read More
While the U.S. waits, China has been CRISPRing human cancer patients since 2015
While the U.S. is just gearing up to the idea of CRISPRing its first humans, China seems to be benefiting from the “move fast and break things” — or cut them with the CRISPR scissors — motto. As The Wall Street Journal reports, China has already gene-edited 86 people using CRISPR-Cas9 since 2015. Unhindered by rules and regulations like the ones we have in America… Read More
Spider silk startup Bolt Threads closes on $123 million in Series D funding
Bolt Threads, the startup making spider silk from microbugs, has raised a giant $123 million Series D round of funding. As we reported in November, an SEC filing showed the company had raised $106 million from Foundation Capital and Formation 8. Bolt now tells TechCrunch it has added to that amount, bringing up its total to $147 million raised so far. Read More